Maxime Annereau

Title: Maxime Annereau: Innovator in Pharmaceutical Solutions

Introduction

Maxime Annereau is a notable inventor based in Vincennes, France. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on temozolomide formulations. His dedication to improving drug delivery systems has positioned him as a key figure in pharmaceutical research.

Latest Patents

Maxime Annereau holds a patent for an oral suspension of temozolomide. This pharmaceutical liquid suspension comprises temozolomide or a salt thereof, at least one agent controlling the solid state of temozolomide in suspension, a pharmaceutically acceptable liquid vehicle, and optionally at least one acid in a quantity so that the pH of the composition is below 5. This invention aims to enhance the bioavailability and effectiveness of temozolomide for patients.

Career Highlights

Throughout his career, Maxime has worked with reputable organizations such as Orphelia Pharma and Institut Gustave Roussy. His experience in these institutions has allowed him to collaborate with leading experts in the pharmaceutical industry and contribute to groundbreaking research.

Collaborations

Maxime Annereau has collaborated with Jérémy Bastid, a fellow professional in the field. Their partnership has fostered innovative approaches to pharmaceutical development and has led to advancements in drug formulation techniques.

Conclusion

Maxime Annereau's contributions to pharmaceutical innovations, particularly in the formulation of temozolomide, highlight his commitment to improving patient care. His work continues to influence the pharmaceutical landscape, paving the way for future advancements.